Stay updated on Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial

Sign up to get notified when there's something new on the Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision tag on the page was updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T19:58:25.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Added an optional tag 'Gastric cancer' and a new 'Genetic and Rare Diseases Information Center' resource under Resources. These changes provide additional context but do not modify the trial details or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-18T07:40:53.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    A new site revision label 'Revision: v3.4.2' has been added. A prior notice about government funding status and operating status (Revision: v3.4.1) is present, but core trial details remain unchanged.
    Difference
    0.5%
    Check dated 2026-02-11T05:34:36.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    A system notice about potential delays due to a lapse in government funding was added, noting that the NIH Clinical Center is open and directing users to cc.nih.gov and opm.gov for updates. The revision banner now shows Revision: v3.4.1, replacing the previous v3.4.0.
    Difference
    0.5%
    Check dated 2026-02-04T05:26:57.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The page now shows the glossary by default, adds a 'Last Update Submitted that Met QC Criteria' entry and a 'Revision: v3.4.0' tag, and adjusts certain labels (e.g., capitalization of 'No FEAR Act data'). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T03:30:01.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.3.4 updates the version from v3.3.3; there is no change to page content, functionality, or user-visible information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:43:05.000Z thumbnail image

Stay in the know with updates to Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial page.